Takeda, Daiichi Sankyo To Increase Production Capacity For Flu Vaccines
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical and Daiichi Sankyo reportedly are engaged in a race to erect plants to allow them to produce additional influenza vaccines by fiscal 2014.